home

clinical

cataract

Clinical

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

Articles

Early experience with next-generation lens engenders positive perception.

Presbyopia-correcting IOL improves vision for patients

Nijm is an ophthalmologist at the Warrenville Eye Care and LASIK, Warrenville, Illinois, and works at the University of Illinois Eye and Ear Infirmary, Chicago, Illinois.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

Novel ophthalmic pharmaceuticals drive innovation, improve outcomes

Advances help gain clearer image, enhancing decision-making process.

Physicians measure contrast sensitivity in patients with cataract

Podcasts

Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients. 

Impact of prior authorization for cataract surgery 

Substantial weight loss can help patients’ eye health, study results show.

Bariatric surgery may lead to decreased risk of cataract

ASCRS Foundation, Aerie raise over $100,000 for cataract surgery patients

Silverstein is a founding partner of Silverstein Eye Centers, in Kansas City, Missouri. He is also an assistant professor of ophthalmology at the University of Missouri Kansas City Medical School, and clinical professor of ophthalmology at Kansas City University of Medicine and Biosciences. 

E: ssilverstein@silversteineyecenters.com

Taking control of a practice’s future with investment, creative thinking

Four tips for growing a proactive practice

Cataract Surgery

Cataract

Videos

Robert Weinstock, MD, discusses the efficacy and safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for eyes receiving cataract surgery.

Evaluating efficacy, safety of intracameral dexamethasone 9% vs topical regimen for cataract surgery

Cathleen McCabe, MD, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

Evaluating dexamethasone intraocular suspension 9% post-cataract surgery

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery. 